Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Our products and services are designed to benefit people and improve their quality of life. At the same time, we aim to create value through innovation, growth and high earning power. Our products help address some of today's biggest challenges, including global population growth, an aging society and the need to make efficient - and, wherever possible, sustainable - use of natural resources. In line with our mission "Bayer: Science For A Better Life," we aim to improve people's quality of life by preventing, alleviating or curing diseases. We also help provide an adequate supply of high-quality food, feed and renewable plant-based raw materials. For these endeavors, we focus on developing and successfully commercializing innovative products and solutions based on scientific knowledge.
75
Total Investments
50
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Agriculture, Biotechnology
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Leaps by Bayer
Recent Investments (75)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series A | •••••• | Jul 2025 | |
| Early VC | •••••• | Dec 2024 | |
| Series D | •••••• | Sep 2024 | |
| Series B | •••••• | Jul 2024 | |
| Series D | •••••• | Jul 2024 | |
|
|
Series A | •••••• | Apr 2024 |
|
|
Series B | •••••• | Mar 2024 |
|
|
Series A | •••••• | Feb 2024 |
|
|
Series D | •••••• | Jan 2024 |
|
|
Series B | •••••• | Jan 2024 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.